SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-22-073942
Filing Date
2022-11-18
Accepted
2022-11-18 19:33:45
Documents
1
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 5019
  Complete submission text file 0001213900-22-073942.txt   6401
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INMED PHARMACEUTICALS INC. SUITE 310 - 815 HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address
WOUDENBERG MICHAEL (Reporting) CIK: 0001817884 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39685 | Film No.: 221403210